Immuneering Corporation
USD5.05
+0.29 (+6.09%)
CEO
Benjamin J. Zeskind
IPO Date
2021-07-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.73
Prev. Close
$4.76
Day Low
$4.73
Day High
$5.14
52W Low
$2.90
52W High
$10.08
Market Cap
$0.18B
Volume
1.92M
| 6,035 |
| $4.15 |
| 11 Jun 2026 | Schall Thomas J. | director | A-Award | Acquired | 33,350 | $4.12 |
| 11 Jun 2026 | HAUSMAN DIANA | director | A-Award | Acquired | 33,350 | $4.12 |
| 11 Jun 2026 | CARPENTER ROBERT J | director | A-Award | Acquired | 33,350 | $4.12 |
| 11 Jun 2026 | KEATING LAURIE | director | A-Award | Acquired | 33,350 | $4.12 |
| 11 Jun 2026 | Feinberg Peter | director | A-Award | Acquired | 33,350 | $4.12 |
| 17 Mar 2026 | Neufeld Leah R | CHIEF PEOPLE OFFICER | A-Award | Acquired | 3,628 | $4.29 |
| 5 Feb 2026 | Bookman Michael | CHIEF LEGAL OFFICER, SECRETARY | A-Award | Acquired | 176,000 | $4.91 |
| 5 Feb 2026 | Brakewood Harold Eugene | Chief Business Officer | A-Award | Acquired | 140,000 | $4.91 |